That is particularly true as most of the warrant, option or convertible share conversions are investors in it for the cash. John Fife's vulture fund cashed in $40 million in interest, fees and settlements in 2020. That was in the range to 20 million shares and they sell theirs fast. Add company options, warrants and preferred conversions and you have a stead stream of shares hitting the market. Now add NP's piggy bank of 200,000,000 that shareholders will likely approve, you can see how much downward pressure the share price will feel. Company has to payoff $65 million in payables, $55 million in vulture debt to begin with. That will likely hit the market soon after the approval as the creditors are impatient. Look at Amarex holding all the clinical data hostage because of $12 million in past due bills.